Epsilon Healthcare Limited (EPN.AX)

0.0240 0.0000 (0.00%) As of 09:37AM AEST. Market open.

Epsilon Healthcare Limited

9 Castlereagh Street
Level 17
Sydney, NSW 2000
Australia

https://epsilonhealthcare.com.au

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Xiao Cui	Executive Chairman	N/A	N/A	N/A
Ms. Diandra Phipps	Chief Operating Officer of Tetra Health	N/A	N/A	N/A
Mr. Daniel Sanghera	Interim Chief Executive Officer	N/A	N/A	N/A
Ms. Li Lin	Group Financial Controller	N/A	N/A	N/A
Mr. Marcelo Mora	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.

Corporate governance

Epsilon Healthcare Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.